Riverview Trust Company’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-162
Closed -$19.4K 592
2025
Q1
$19.4K Hold
162
0.02% 439
2024
Q4
$18.8K Sell
162
-6
-4% -$759 0.02% 496
2024
Q3
$22.7K Buy
168
+6
+4% +$803 0.02% 413
2024
Q2
$22K Hold
162
0.02% 394
2024
Q1
$20.9K Buy
+162
New +$19.6K 0.02% 455
2023
Q4
Sell
-162
Closed -$14.7K 650
2023
Q3
$14.7K Hold
162
0.01% 549
2023
Q2
$18.2K Hold
162
0.02% 401
2023
Q1
$17K Hold
162
0.02% 412
2022
Q4
$18K Hold
162
0.02% 365
2022
Q3
$14K Buy
+162
New +$14.7K 0.01% 484
2022
Q2
Sell
-306
Closed -$26K 879
2022
Q1
$26K Buy
+306
New +$29.3K 0.02% 381

Other funds holding XYL

Riverview Trust Company's XYL Position: Q2 2025 in Review

Riverview Trust Company sold out of Xylem (XYL) in Q2 2025, closing a stake of 162 shares — an estimated $19.4K sold.

Riverview Trust Company first reported a position in XYL in Q1 2022 and held it in 11 quarters. The position peaked at $26K in Q1 2022. 1,063 funds tracked by Wall St. Rank hold XYL as of Q2 2025.

  • Riverview Trust Company reported no remaining Xylem position as of Q2 2025 after selling out during the quarter.
  • Riverview Trust Company sold 162 Xylem shares in Q2 2025, an estimated $19.4K.
  • Riverview Trust Company first reported a position in Xylem in Q1 2022 and held it in 11 quarters.
  • Riverview Trust Company's Xylem position peaked at $26K in Q1 2022.
  • 1,063 funds tracked by Wall St. Rank held Xylem as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.